# Constitutional Pharma Overview
## Fixed‑Point Constitutional Framework for Pharmaceutical Admissibility

The Constitutional Pharma Framework defines how pharmaceutical entities are
evaluated using **deterministic predicates**, **WAD arithmetic**, and
**constitutional axioms**. It replaces heuristic or statistical quality control
with explicit, reproducible, and auditable constitutional rules.

Normative Reference:  
Russell, “Constitutional Mathematics for Pharma” (SSRN‑6816078, 2026)

---

## 1. Purpose of the Constitutional Pharma Layer

The constitutional layer ensures:

- deterministic admissibility  
- zero ambiguity in thresholds  
- cross‑batch reproducibility  
- explicit impurity, stability, and reproducibility gates  
- formal classification into fixed‑point classes (F2, F3, etc.)  

This layer is **implementation‑agnostic** and applies to any lab, LIMS, or
computational system.

---

## 2. The Three Constitutional Gates

Pharmaceutical admissibility is governed by three constitutional axioms:

### 2.1 Axiom VI — Purity Gate  
Ensures impurity does not exceed the constitutional threshold.

### 2.2 Axiom VII — Stability Gate  
Ensures stability remains above the constitutional minimum envelope.

### 2.3 Axiom VIII — Reproducibility Gate  
Ensures cross‑batch reproducibility meets constitutional requirements.

All three gates must be satisfied before any entity can be considered for F2.

---

## 3. Fixed‑Point Classes (F‑Classes)

Pharmaceutical entities are classified into fixed‑point classes:

### F0  
Non‑admissible; fails at least one constitutional gate.

### F1  
Partially admissible; meets some but not all constitutional requirements  
(used only for diagnostic purposes).

### F2  
Fully admissible; satisfies all three constitutional gates.

### F3  
Advanced classification for entities that exceed constitutional minima  
and demonstrate enhanced reproducibility or stability.

Only F2 and F3 entities are eligible for downstream constitutional evaluation.

---

## 4. Constitutional Evaluation Tuple

All pharmaceutical evaluations produce:

\[
E(Y) \rightarrow (s, c, h, F, R)
\]

Where:

- **s** — WAD‑scaled score  
- **c** — compliance flag  
- **h** — hard breach flag  
- **F** — finding  
- **R** — remedy  

This tuple is deterministic and implementation‑independent.

---

## 5. WAD Arithmetic in Pharma

All impurity, stability, and reproducibility metrics are expressed in:

\[
10^{18} \text{ fixed‑point (WAD)}
\]

Examples:

- 0.1% impurity → \(0.001 \times 10^{18}\)  
- 99% stability → \(0.99 \times 10^{18}\)  
- 97% reproducibility → \(0.97 \times 10^{18}\)

This ensures exactness and cross‑platform reproducibility.

---

## 6. Hard Breach Semantics

A hard breach occurs when:

- impurity > threshold  
- stability < threshold  
- reproducibility < threshold  

Hard breaches:

- override all other considerations  
- prevent F2 classification  
- require rejection or destruction  
- cannot be remediated  

These are constitutional red lines.

---

## 7. Implementation Independence

This document defines the **constitutional layer**, not the implementation.

Any implementation (LIMS, lab systems, Solidity, Rust
